West Pharmaceutical Services, Inc [NYSE: WST] traded at a low on Thursday, posting a -38.22 loss after which it closed the day’ session at $199.11.
The results of the trading session contributed to over 5165041 shares changing hands. Over the past one week, the price volatility of West Pharmaceutical Services, Inc stands at 7.35% while the volatility over the past one month is 3.60%.
The market cap for WST stock reached $14.42 billion, with 72.50 million shares outstanding and 71.98 million shares in the current float. Compared to the average trading volume of 495.70K shares, WST reached a trading volume of 5165041 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about West Pharmaceutical Services, Inc [WST]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for WST shares is $357.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on WST stock is a recommendation set at 1.73. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for West Pharmaceutical Services, Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 08, 2025. While these analysts kept the previous recommendation, Wolfe Research raised their target price to Peer Perform. The new note on the price target was released on December 13, 2024, representing the official price target for West Pharmaceutical Services, Inc stock. Previously, the target price had yet another raise from $350 to $390, while UBS kept a Buy rating on WST stock. On February 07, 2024, analysts increased their price target for WST shares from 323 to 536.
The Average True Range (ATR) for West Pharmaceutical Services, Inc is set at 16.59, with the Price to Sales ratio for WST stock in the period of the last 12 months amounting to 5.01. The Price to Book ratio for the last quarter was 5.25, with the Price to Cash per share for the same quarter was set at 6.78. Price to Free Cash Flow for WST in the course of the last twelve months was 44.84 with Quick ratio for the last quarter at 2.23.
How has WST stock performed recently?
West Pharmaceutical Services, Inc [WST] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -39.75. With this latest performance, WST shares dropped by -39.47% in over the last four-week period, additionally sinking by -32.60% over the last 6 months – not to mention a drop of -51.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for WST stock in for the last two-week period is set at 11.01, with the RSI for the last a single of trading hit 6.26, and the three-weeks RSI is set at 16.15 for West Pharmaceutical Services, Inc [WST]. The present Moving Average for the last 50 days of trading for this stock 328.97, while it was recorded at 297.89 for the last single week of trading, and 319.67 for the last 200 days.
West Pharmaceutical Services, Inc [WST]: Deeper insight into the fundamentals
West Pharmaceutical Services, Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.23 and a Current Ratio set at 3.00.
Earnings analysis for West Pharmaceutical Services, Inc [WST]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for WST. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for West Pharmaceutical Services, Inc go to 3.24%.
Insider trade positions for West Pharmaceutical Services, Inc [WST]
The top three institutional holders of WST stocks are: VANGUARD GROUP INC with ownership of 8.94 million shares, which is approximately 12.1685%. BLACKROCK INC., holding 7.58 million shares of the stock with an approximate value of $$2.5 billion in WST stocks shares; and BLACKROCK INC., currently with $$1.08 billion in WST stock with ownership which is approximately 4.4543%.
